# The Clinical Study of the Safety and Efficacy of Istaroxime in Treatment of Acute Decompensated Heart Failure

> **NCT02617446** · PHASE2 · COMPLETED · sponsor: **Windtree Therapeutics** · enrollment: 120 (actual)

## Conditions studied

- Acute Decompensated Heart Failure

## Interventions

- **DRUG:** Placebo
- **DRUG:** Istaroxime

## Key facts

- **NCT ID:** NCT02617446
- **Lead sponsor:** Windtree Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2018-08-14
- **Final completion:** 2019-02-06
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2023-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02617446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02617446, "The Clinical Study of the Safety and Efficacy of Istaroxime in Treatment of Acute Decompensated Heart Failure". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02617446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*